Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Juni 2019 07:30 ET | Quelle: Neuronetics

Neuronetics to Present at the JMP Life Sciences Conference

MALVERN, Pa., June 05, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
03. Juni 2019 07:30 ET | Quelle: Neuronetics

NeuroStar® Advanced Therapy Receives National Reimbursement Listing in Japan

MALVERN, Pa., June 03, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
23. Mai 2019 16:30 ET | Quelle: Neuronetics

Neuronetics to Present at the William Blair 39th Annual Growth Stock Conference

MALVERN, Pa., May 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the...
07. Mai 2019 07:30 ET | Quelle: Neuronetics

Neuronetics Reports First Quarter 2019 Financial and Operating Results

MALVERN, Pa., May 07, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
23. April 2019 08:00 ET | Quelle: Neuronetics

Neuronetics to Report First Quarter 2019 Financial and Operating Results and Host Conference Call

MALVERN, Pa., April 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
27. März 2019 16:15 ET | Quelle: Neuronetics

NeuroStar® Advanced Therapy to Receive Reimbursement Approval in Japan

MALVERN, Pa., March 27, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
26. März 2019 08:00 ET | Quelle: Neuronetics

Neuronetics to Present at the 18th Annual Needham & Company Healthcare Conference

MALVERN, Pa., March 26, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
05. März 2019 07:00 ET | Quelle: Neuronetics

Neuronetics Reports Fourth Quarter and Full Year 2018 Financial and Operating Results

MALVERN, Pa., March 05, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
19. Februar 2019 16:15 ET | Quelle: Neuronetics

Neuronetics to Report Fourth Quarter and Fiscal Year 2018 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
15. Februar 2019 08:00 ET | Quelle: Neuronetics

Neuronetics, Inc. Announces Appointment of Dr. Cheryl R. Blanchard to its Board of Directors

MALVERN, Pa., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...

Vorherige Seite